“Horse racing in the U.S. faces significant challenges to its long-term health. The leadership of the American Association of Equine Practitioners (AAEP) reviews with interest the announcement by a cohort of Thoroughbred racing organizations that they will ban the use of furosemide in 2-year-old racing in 2020 and graded stakes races in 2021.  The landscape is changing.

“As Doctors of Veterinary Medicine, science and evidence-based discovery is our foundation, and as such, the AAEP’s long-standing racehorse medication policy has supported the administration of furosemide on race day to mitigate the adverse effects of exercise-induced pulmonary hemorrhage (EIPH).

“The AAEP also is committed to funding research into alternative EIPH management strategies which would eliminate the need to administer furosemide on race day. The proposed phase-out of the medication’s use beginning at many Thoroughbred racetracks in 2020 emphasizes the urgent need for continued research into new methods for mitigating EIPH.

“Regarding the daily care of horses adversely affected by EIPH, the AAEP urges a strong partnership between owners, trainers and veterinarians in order to optimally manage the syndrome and make decisions in the best interest of the health and welfare of the horse.”

Post Type

  • Press Release

Publish Date

April 19, 2019

Related Articles

May 16, 2024

Horse Doctors to Expand Lameness, Musculoskeletal Imaging and Ophthalmology Skills at AAEP’s Focus on Field Medicine

Equine veterinarians will grow their toolbox of field medicine diagnostic techniques and…

Biometric Sensors
May 10, 2024

AAEP Project for Wearable Biometric Sensor Development Advancing to Next Phase

Thoroughbred industry participation needed for testing, validation  The American Association of Equine…

AAEP On Call
May 1, 2024

AAEP On Call Program to Serve Triple Crown Telecasts

Two veterinarian-members of the American Association of Equine Practitioners will represent the…